(19)
(11) EP 0 723 438 A1

(12)

(43) Date of publication:
31.07.1996 Bulletin 1996/31

(21) Application number: 94927761.0

(22) Date of filing: 03.10.1994
(51) International Patent Classification (IPC): 
C07D 277/ 20( . )
A61K 31/ 13( . )
A61K 31/ 155( . )
A61K 31/ 165( . )
A61K 31/ 215( . )
A61K 31/ 426( . )
A61P 3/ 00( . )
A61P 9/ 10( . )
A61P 43/ 00( . )
C07C 275/ 26( . )
C07C 275/ 70( . )
C07C 335/ 30( . )
C07D 213/ 75( . )
C07D 277/ 42( . )
A61K 31/ 00( . )
A61K 31/ 135( . )
A61K 31/ 16( . )
A61K 31/ 195( . )
A61K 31/ 425( . )
A61K 31/ 44( . )
A61P 9/ 00( . )
A61P 25/ 28( . )
C07C 275/ 16( . )
C07C 275/ 28( . )
C07C 281/ 06( . )
C07C 335/ 32( . )
C07D 277/ 18( . )
(86) International application number:
PCT/GB1994/002138
(87) International publication number:
WO 1995/009619 (13.04.1995 Gazette 1995/16)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT SI

(30) Priority: 04.10.1993 US 19930131794
01.06.1994 EP 19940303939

(71) Applicant: THE WELLCOME FOUNDATION LIMITED
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • OPLINGER, Jeffrey Alan
    Cary, NC 27513 (US)
  • SHEARER, Barry George
    Cary, NC 27513 (US)
  • BIGHAM, Eric Cleveland
    Chapel Hill, NC 27514 (US)
  • FURFINE, Eric Steven
    Durham, NC 27707 (US)
  • GARVEY, Edward Patrick
    Chapel Hill, NC 27516 (US)

(74) Representative: Stott, Michael John, et al 
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN
Greenford, Middlesex UB6 0NN (GB)

   


(54) SUBSTITUTED UREA AND ISOTHIOUREA DERIVATIVES AS NO SYNTHASE INHIBITORS